Literature DB >> 15830272

Risk factors for bleeding complications in percutaneous renal biopsy.

Masaaki Eiro1, Tetsuo Katoh, Tsuyoshi Watanabe.   

Abstract

BACKGROUND: Among the complications in percutaneous renal biopsy, bleeding is the most frequent and sometimes becomes fatal.
METHODS: We prospectively studied 394 consecutive percutaneous renal biopsies in 359 patients (male/female = 188/171). The mean age of the patients was 44.0 +/- 17.2 years. Percutaneous renal biopsies were performed on native kidneys under direct visualization by ultrasound, using an automated spring-loaded biopsy device and a 16-cm 18 G needle.
RESULTS: The most common complication was hematoma (n = 149, 37.8%). "De novo macrohematuria" was observed in 29 patients (7.4%). Other complications included pain (n = 27, 6.9%), loss of blood (n = 17, 4.3%), and renal dysfunction (increase of serum creatinine more than 0.2 mg/dl, n = 9, 2.2%). Although there were no severe complications such as loss of blood requiring a blood transfusion, loss of kidney function, or death, 10 patients had an extended rest period in bed because of moderate complications. Hypertension and amyloidosis had significant influence on the complications.
CONCLUSIONS: For those who are clinically suspected of having amyloidosis or hypertension, more careful biopsy procedures and observations are necessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15830272     DOI: 10.1007/s10157-004-0326-7

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  60 in total

1.  Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis.

Authors:  Siranush A Sargsyan; Natalie J Serkova; Brandon Renner; Kendra M Hasebroock; Brian Larsen; Conrad Stoldt; Kim McFann; Matthew C Pickering; Joshua M Thurman
Journal:  Kidney Int       Date:  2011-09-28       Impact factor: 10.612

Review 2.  The Native Kidney Biopsy: Update and Evidence for Best Practice.

Authors:  Jonathan J Hogan; Michaela Mocanu; Jeffrey S Berns
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 8.237

3.  Evaluating renal biopsy-associated hemorrhage complications by the equation and providing an early intervention: a single-center experience.

Authors:  Chao Wang; Yang Yang; Liping Jin; Ying Zhang; Guanglei Chen; Zhuliang Zhou; Minghui Song; Qingman Gao; Changchun Li; Tao Pan; Fagui He; Lu Ma
Journal:  J Nephrol       Date:  2015-04-15       Impact factor: 3.902

4.  Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.

Authors:  Mingao Wang; Rujuan Xie; Xibei Jia; Ruichan Liu
Journal:  Med Princ Pract       Date:  2017-06-19       Impact factor: 1.927

5.  A man with new onset of ascites and edema.

Authors:  Melvin Lau
Journal:  Medscape J Med       Date:  2008-04-09

6.  Biopsy: observation time after kidney biopsy: when to discharge?

Authors:  Christina M Yuan; Rahul M Jindal; Kevin C Abbott
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

7.  Diagnosis: should renal biopsies be performed in the very elderly?

Authors:  J Ashley Jefferson; Charles E Alpers
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

Review 8.  Complications of Percutaneous Renal Biopsy.

Authors:  Kenaz Bakdash; Kristofer M Schramm; Aparna Annam; Matthew Brown; Kimi Kondo; Jonathan D Lindquist
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

9.  Application of Proteomic Analysis to Renal Disease in the Clinic.

Authors:  Bruce A Julian; Hitoshi Suzuki; Goce Spasovski; Yusuke Suzuki; Yasuhiko Tomino; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2009-01-01       Impact factor: 3.494

10.  Prospective Randomized Trial for Image-Guided Biopsy Using Cone-Beam CT Navigation Compared with Conventional CT.

Authors:  Nadine Abi-Jaoudeh; Teresa Fisher; John Jacobus; Marlene Skopec; Alessandro Radaelli; Imramsjah Martijn Van Der Bom; Robert Wesley; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2016-07-25       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.